Reliability of self-reported diagnostic radiation history in BRCA1/2 mutation carriers
- PMID: 20066476
- DOI: 10.1007/s10654-009-9416-x
Reliability of self-reported diagnostic radiation history in BRCA1/2 mutation carriers
Abstract
We assessed reliability of self-reported diagnostic radiation history in BRCA1/2 mutation carriers with and without breast cancer. Within the frame-work of the HEBON study, 401 BRCA1/2 mutation carriers completed a baseline (1999-2004) and a follow-up questionnaire (2006-2007). Test-retest reliability of self-reported exposure to chest X-rays, fluoroscopies and mammograms was assessed for the entire study population and by case status.Overall proportion agreement on reporting ever/never exposure was good ([75%), while the corresponding kappa coefficients were between 0.40 and 0.75, indicating at least moderate reliability beyond chance. Reliability of number of exposures was also good ([75%). Proportion agreement on reporting age at first mammogram was low(40%) for exact consistency and moderate (60%) for consistency +/- 1 year. Reliability of age at first mammogram was higher for cases than for unaffected carriers(P\0.001) but this difference disappeared when excluding diagnostic mammograms (P = 0.60). In unaffected carriers proportion agreement on age at last mammogram was 50%. In general, the direction of disagreement on all items was equally distributed. More consistent reporting was mainly determined by a younger age at questionnaire completion. In conclusion, inconsistent self-report of diagnostic radiation by BRCA1/2 mutation carriers was mainly non-differential by disease status.
Similar articles
-
Diagnostic chest X-rays and breast cancer risk before age 50 years for BRCA1 and BRCA2 mutation carriers.Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1547-56. doi: 10.1158/1055-9965.EPI-13-0189. Epub 2013 Jul 12. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23853209 Free PMC article.
-
Validation study suggested no differential misclassification of self-reported mammography history in BRCA1/2 mutation carriers.J Clin Epidemiol. 2011 Dec;64(12):1434-43. doi: 10.1016/j.jclinepi.2011.04.005. Epub 2011 Jul 20. J Clin Epidemiol. 2011. PMID: 21764559
-
Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group.J Clin Oncol. 2006 Jul 20;24(21):3361-6. doi: 10.1200/JCO.2005.03.3126. Epub 2006 Jun 26. J Clin Oncol. 2006. PMID: 16801631
-
Diagnostic and therapeutic ionizing radiation and the risk of a first and second primary breast cancer, with special attention for BRCA1 and BRCA2 mutation carriers: a critical review of the literature.Cancer Treat Rev. 2015 Feb;41(2):187-96. doi: 10.1016/j.ctrv.2014.12.002. Epub 2014 Dec 8. Cancer Treat Rev. 2015. PMID: 25533736 Review.
-
Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature.Breast Cancer Res Treat. 2010 Feb;120(1):119-26. doi: 10.1007/s10549-009-0685-6. Epub 2009 Dec 24. Breast Cancer Res Treat. 2010. PMID: 20033769 Review.
Cited by
-
Diagnostic chest X-rays and breast cancer risk before age 50 years for BRCA1 and BRCA2 mutation carriers.Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1547-56. doi: 10.1158/1055-9965.EPI-13-0189. Epub 2013 Jul 12. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23853209 Free PMC article.
-
Lack of validity of self-reported mammography data.Fam Med Community Health. 2019 Jan 29;7(1):e000096. doi: 10.1136/fmch-2018-000096. eCollection 2019. Fam Med Community Health. 2019. PMID: 32148699 Free PMC article.
-
Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK).BMJ. 2012 Sep 6;345:e5660. doi: 10.1136/bmj.e5660. BMJ. 2012. PMID: 22956590 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous